Iparomlimab and Tovorilimab Combined with Bevacizumab in Advanced Ovarian Cancer Trial
A clinical trial is underway to assess the safety and efficacy of iparomlimab and tovorilimab combined with standard chemotherapy for advanced ovarian cancer.
Asset / Drug
Drug and asset intelligence for Iparomlimab with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.